Procter & Gamble (PG, $142.62) posts fall in quarterly earnings amid slump in sales volume
Procter & Gamble Co. posted lower quarterly profit, amidst higher prices dampening sales volumes. It is among the first consumer product behemoths to report December quarter results.
For the three months ended Dec. 31, the company reported net income of $3.9 billion, or $1.59 per share, excluding items, lower than $4.22 billion, or $1.66 per share, a year earlier. The EPS were in line with analysts’ expectations (based on Refinitiv data).
Net sales fell -1% year-over-year to $20.77 billion, exceeding analysts' forecast of $20.73 billion.
P&G’s sales volumes decreased -6% in the three months ended Dec. 31 —the biggest quarterly drop in years. Each of the company’s five major business units underwent lower sales volume compared with a year earlier. P&G increased prices by +10% in the period, leading to a +5% growth in organic sales (which exclude currency fluctuations and acquisitions).
The company’s quarterly results were in line with consensus forecasts, according to estimates compiled by FactSet.
The Wall Street Journal reported that P&G finance chief Andre Schulten said that the company had anticipated the volume decreases and attributed half of the decline to a combination of P&G ending sales of all but essential items in Russia and retailer inventory reductions in the U.S., Europe and in China.
P&G projects growth in the consumer-products market will continue but slow to 3% to 4% growth, from a 5% to 6% range. Pricing is expected to continue to drive growth, while volumes are anticipated to decrease further, according to the company.
PG's RSI Indicator recovers from oversold territory
The RSI Indicator for PG moved out of oversold territory on January 16, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In of the 26 cases the stock moved higher. This puts the odds of a move higher at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on January 22, 2025. You may want to consider a long position or call options on PG as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PG just turned positive on January 22, 2025. Looking at past instances where PG's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
PG moved above its 50-day moving average on February 03, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PG advanced for three days, in of 355 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
PG broke above its upper Bollinger Band on January 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PG entered a downward trend on January 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.918) is normal, around the industry mean (17.160). P/E Ratio (26.898) is within average values for comparable stocks, (204.360). Projected Growth (PEG Ratio) (3.395) is also within normal values, averaging (3.832). Dividend Yield (0.023) settles around the average of (0.107) among similar stocks. P/S Ratio (4.733) is also within normal values, averaging (115.095).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a provider of branded consumer packaged goods
Industry HouseholdPersonalCare